The #1 Medical Tourism Platform since 2014
Patient Safety
Patient Safety
China, Shanghai

CAR T-cell therapy in Shanghai Tongji Hospital, International Department

11 patients
chose clinic for Hematology Oncology Treatment

About the clinic

CAR T-cell therapy at the International Department of Shanghai Tongji Hospital in China is a specialized treatment for blood cancers. The hospital is a leading center for this method, focusing on patients with lymphoma, leukemia, and multiple myeloma. This facility is a university-affiliated hospital certified by the National Health Commission.

Experience and Success Rates

The medical team has performed 1,500+ CAR-T infusions since starting the program in 2014. This high volume makes it one of the most experienced centers for cell therapy globally. Patients with lymphoma have shown strong results at this facility. Data shows a complete remission rate of about 87.5% at the three-month mark for these cases. The hospital also publishes its research in major journals like Nature Cancer.

Standardized Treatment Pathway

The hospital follows a strict process to manage patient safety and cell quality. The treatment includes several specific stages:

  • Patient selection using immunophenotyping to check eligibility.
  • Cell preparation where the patient’s T-cells are modified in a lab.
  • Bridging therapy to stabilize the patient before the infusion.
  • Infusion of the modified cells back into the bloodstream.
  • Long-term follow-up to monitor the patient's recovery.

Advanced Care and Research

A multidisciplinary tumor board manages every case. This team includes experts in hematology, radiology, and pathology. They also provide nutrition and psychological support during the hospital stay. For high-risk cases that do not respond to standard care, the hospital uses epigenetic immunotherapy. The center is also developing next-generation treatments, such as CAR-NK cell therapies, through active clinical trials.

Diagnostic Tools

Doctors use precise tools to plan the treatment and monitor its effects. These include biopsy and imaging-guided assessments to track the tumor's response. The team also uses detailed lab tests to make sure the patient is a good candidate for the therapy. This helps the medical staff choose the right strategy for refractory or relapsed cancers.

If you are looking for advanced cell therapy options, you can leave a request on Bookimed to receive more information about the program in Shanghai.

Highlights

2018 Year of foundation
24 doctors
Most Popular Clinic for CAR T-cell therapy
10000 patients per year

Get a free consultation

Shanghai Tongji Hospital, International Department
plus-square Individual treatment program and cost estimate
clock Average answering time – 5 minutes

Accepted payment methods

No payment is needed now. You will be charged directly at the clinic when you arrive.
View more information

Treatments prices in the clinic

Last price update — 29.03.2025. Prices can be changed depending on the medical case and doctor's recommendations.
Oncology
diagnostics Price
Online Consultation with Hematologist $500
treatment Price
CAR-T for Pediatric ALL $250000 - $280000
CAR-T for Multiple Myeloma $250000 - $280000
CAR-T for DLBCL $250000 - $280000
CAR T-cell therapy Price on request
Bone marrow transplantation Price on request
Chemotherapy Price on request
Leukemia chemotherapy Price on request
Lymphoma chemotherapy Price on request

Clinic Doctors

How are we doing?

question icon
1 of 3
Information about this clinic is full and clear
1
2
3
4
5
Strongly disagree
Strongly agree

Licences

Clinic license for Shanghai Tongji Hospital, International Department, issued by Shanghai Health Commission, 2024

Shanghai Tongji Hospital, International Department: more details about the clinic

China, Shanghai

Shanghai Tongji Hospital (Shanghai Tongji Hospital), affiliated with Tongji University, is a major public tertiary hospital in Shanghai and one of China’s leading centers for hematology and blood cancer treatment, including lymphoma, leukemia, and multiple myeloma. The Hematology Department and Blood-Tumor Clinical Research Center specialize in advanced cellular immunotherapy, including CAR-T and CAR-NK therapies.

The hospital established its CAR-T program in 2014 and has since performed more than 1,500 CAR-T cell infusions, making it one of the most experienced centers in this field. Over years of clinical development, the team has built a standardized treatment pathway covering patient selection, cell preparation, bridging therapy, infusion, and long-term follow-up. Reported outcomes include a 3-month complete remission rate of approximately 87.5% in lymphoma patients.

For high-risk and refractory cases, the hospital has developed combination approaches such as CAR-T based therapies integrated with additional treatment strategies, improving long-term remission outcomes in selected patient groups. The center has also contributed to the development of innovative approaches such as epigenetic immunotherapy for patients who have not responded to multiple prior treatments.

In lymphoma care, particularly diffuse large B-cell lymphoma (DLBCL), the hospital reports high clinical effectiveness, including strong remission rates in both newly diagnosed and relapsed or refractory cases, significantly improving outcomes compared to conventional therapies.

The hospital is actively involved in global research and clinical innovation, including publications on next-generation CAR-NK cell therapies in leading scientific journals such as Nature Cancer. Its research focuses on improving accessibility, durability, and safety of cellular immunotherapy.

Patient care is organized through a multidisciplinary tumor board involving hematology, radiology, pathology, imaging, nutrition, and psychological support specialists. Advanced diagnostic tools include immunophenotyping for CAR-T eligibility, biopsy techniques, and imaging-guided assessments to ensure precise treatment planning.

Shanghai Tongji Hospital is recognized for its extensive clinical experience in CAR-T therapy, participation in clinical trials, high remission outcomes in lymphoma treatment, and contribution to international research in cellular immunotherapy.

Additional services
Transfer
Clinic to airport
free
Airport to clinic
free
Language assistance
Available
free
Accommodation
Hotel (apartments) near the clinic, billed daily
Requirements for admission
Payment methods
Cash
Age
0 - 70

Patient reviews

image Google 0
4 Google reviews

Wanyang Qiao

Mar 4, 2024

Chung Wah, John Chau

Dec 22, 2019

Maxim Beatty

Jan 6, 2017
Newly renovated hospital. It's okay. Not fantastic. Good value health checks on the top floor.

Jay Chen

May 10, 2011

200 Renmin Ave, People's Square, Huang Pu Qu, Shang Hai Shi, China, 200003

partner avatar
Information provided by
Shanghai Tongji Hospital - International Department (Healthy Choice)
Clinic’s representative
updated 9/18/2026

Get a free consultation

Shanghai Tongji Hospital, International Department
plus-square Individual treatment program and cost estimate
clock Average answering time – 5 minutes

How it works:

  • We find a medical coordinator familiar with the matter
  • You get a personal offer with a step-by-step guide and the cost estimate
  • We arrange your travel including appointment scheduling and flights booking
  • You arrive at the hospital, we support you 24/7

Popular clinics

Download Bookimed App to get beauty deals

Bookimed App